Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldman

Showing results (81-90 of 488) with videos related to

Pageof 49
Sort By:
Journal of Molecular Evolution|January 7, 2016
The TIM Barrel Architecture Facilitated the Early Evolution of Protein-Mediated MetabolismAaron David Goldman, Joshua T Beatty, Laura F Landweber
Journal of Cataract and Refractive Surgery|September 29, 2009
Intraocular lens exchange surgery in dissatisfied patients with refractive intraocular lensesAnat Galor, Maricely Gonzalez, David Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrierRongbao Zhao, Feng Gao, Marie Hanscom, et al.
Cancer Research|November 20, 2002
A novel folate transport activity in human mesothelioma cell lines with high affinity and specificity for the new-generation antifolate, pemetrexedYanhua Wang, Rongbao Zhao, Shrikanta Chattopadhyay, et al.
Nature Reviews. Neuroscience|October 21, 2011
Pharmacogenetic approaches to the treatment of alcohol addictionMarkus Heilig, David Goldman, Wade Berrettini, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogsI David Goldman, Shrikanta Chattopadhyay, Rongbao Zhao, et al.
American Journal of Physiology. Cell Physiology|September 24, 2004
Preservation of folate transport activity with a low-pH optimum in rat IEC-6 intestinal epithelial cell lines that lack reduced folate carrier functionYanhua Wang, Arun Rajgopal, I David Goldman, et al.
Cancer Research|May 6, 2004
Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathwayRongbao Zhao, Marie Hanscom, Shrikanta Chattopadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrierRongbao Zhao, Shrikanta Chattopadhyay, Marie Hanscom, et al.
American Journal of Physiology. Cell Physiology|November 24, 2017
Substituted-cysteine accessibility and cross-linking identify an exofacial cleft in the 7th and 8th helices of the proton-coupled folate transporter (SLC46A1)Srinivas Aluri, Rongbao Zhao, Andras Fiser, et al.
Pageof 49

Showing results (81-90 of 488) with videos related to

Sort By:
Pageof 49
Journal of Molecular Evolution|January 7, 2016
The TIM Barrel Architecture Facilitated the Early Evolution of Protein-Mediated MetabolismAaron David Goldman, Joshua T Beatty, Laura F Landweber
Journal of Cataract and Refractive Surgery|September 29, 2009
Intraocular lens exchange surgery in dissatisfied patients with refractive intraocular lensesAnat Galor, Maricely Gonzalez, David Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrierRongbao Zhao, Feng Gao, Marie Hanscom, et al.
Cancer Research|November 20, 2002
A novel folate transport activity in human mesothelioma cell lines with high affinity and specificity for the new-generation antifolate, pemetrexedYanhua Wang, Rongbao Zhao, Shrikanta Chattopadhyay, et al.
Nature Reviews. Neuroscience|October 21, 2011
Pharmacogenetic approaches to the treatment of alcohol addictionMarkus Heilig, David Goldman, Wade Berrettini, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogsI David Goldman, Shrikanta Chattopadhyay, Rongbao Zhao, et al.
American Journal of Physiology. Cell Physiology|September 24, 2004
Preservation of folate transport activity with a low-pH optimum in rat IEC-6 intestinal epithelial cell lines that lack reduced folate carrier functionYanhua Wang, Arun Rajgopal, I David Goldman, et al.
Cancer Research|May 6, 2004
Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathwayRongbao Zhao, Marie Hanscom, Shrikanta Chattopadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrierRongbao Zhao, Shrikanta Chattopadhyay, Marie Hanscom, et al.
American Journal of Physiology. Cell Physiology|November 24, 2017
Substituted-cysteine accessibility and cross-linking identify an exofacial cleft in the 7th and 8th helices of the proton-coupled folate transporter (SLC46A1)Srinivas Aluri, Rongbao Zhao, Andras Fiser, et al.
Pageof 49